National Center on Minority Health and Health Disparities; Notice of Meeting, 28262-28263 [2010-12153]
Download as PDF
<![CDATA[
28262
Federal Register / Vol. 75, No. 97 / Thursday, May 20, 2010 / Notices
MATTERS TO BE DISCUSSED: The meeting
will include the initial review,
discussion, and evaluation of
applications received in response to
‘‘Improved Diagnostics Lyme
Borreliosis,’’ FOA CK10–005.
FOR MORE INFORMATION CONTACT:
Christine J. Morrison, PhD, Scientific
Review Officer, CDC, 1600 Clifton Road,
NE., Mailstop D72, Atlanta, GA 30333,
Telephone: (404) 639–3098.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both CDC
and the Agency for Toxic Substances
and Disease Registry.
Dated: May 6, 2010.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2010–12167 Filed 5–19–10; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
wwoods2 on DSK1DXX6B1PROD with NOTICES_PART 1
Office of the Director, National
Institutes of Health; Notice of Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable materials,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
Name of Committee: Advisory Committee
to the Director, NIH.
Date: June 10, 2010.
Closed: 8:30 a.m. to 9:30 p.m.
Agenda: The ACD review of the Pioneer
and Innovator Awards.
VerDate Mar<15>2010
15:45 May 19, 2010
Jkt 220001
Place: National Institutes of Health,
Building 31, Conference Room 6, 9000
Rockville Pike, Bethesda, MD 20892.
Open: 9:30 a.m. to 5 p.m.
Agenda: Among the topics proposed for
discussion are: (1) NIH Director’s Report; (2)
Work Group for Human Embryonic Stem Cell
Review; (3) Work Group on Outside Awards
for NIH Employees.
Place: National Institutes of Health,
Building 31, Conference Room 6, 9000
Rockville Pike, Bethesda, MD 20852.
Contact Person: Penny W. Burgoon, PhD,
Senior Assistant to the Deputy Director,
Office of the Director, National Institutes of
Health, 1 Center Drive, Building 1, Room
114, Bethesda, MD 20892.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit.
Information is also available on the Office
of the Director’s home page: https://
www.nih.gov/about/director/acd.htm, where
an agenda and any additional information for
the meeting will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.14, Intramural Research
Training Award; 93.22, Clinical Research
Loan Repayment Program for Individuals
from Disadvantaged Backgrounds; 93.232,
Loan Repayment Program for Research
Generally; 93.39, Academic Research
Enhancement Award; 93.936, NIH Acquired
Immunodeficiency Syndrome Research Loan
Repayment Program; 93.187, Undergraduate
Scholarship Program for Individuals from
Disadvantaged Backgrounds, National
Institutes of Health, HHS)
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Center for
Research Resources Special Emphasis Panel.
Date: June 1, 2010.
Time: 11 a.m. to 1 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, NCRR,
OR, One Democracy Plaza, 6701 Democracy
Blvd., Rm. 1064, Bethesda, MD 20892.
Contact Person: Guo Zhang, MD, PhD,
Scientific Review Officer, Office of Review,
National Center for Research Resources,
National Institutes of Health, 6701
Democracy Blvd., 1 Democracy Plaza, Rm.
1064, Bethesda, MD 20892–4874, 301–435–
0812, zhanggu@mail.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the urgent
need to meet timing limitations imposed by
the intramural research review cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research; 93.371, Biomedical
Technology; 93.389, Research Infrastructure;
93.306, 93.333, 93.702, ARRA Related
Construction Awards, National Institutes of
Health, HHS)
Dated: May 14, 2010.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2010–12159 Filed 5–19–10; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Dated: May 14, 2010.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
National Institutes of Health
[FR Doc. 2010–12160 Filed 5–19–10; 8:45 am]
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the
National Advisory Council on Minority
Health and Health Disparities.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public in accordance with the
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Center for Research
Resources; Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
PO 00000
Frm 00033
Fmt 4703
Sfmt 4703
National Center on Minority Health and
Health Disparities; Notice of Meeting
E:\FR\FM\20MYN1.SGM
20MYN1
Federal Register / Vol. 75, No. 97 / Thursday, May 20, 2010 / Notices
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications
and/or contract proposals and the
discussions could disclose confidential
trade secrets or commercial property
such as patentable material, and
personal information concerning
individuals associated with the grant
applications and/or contract proposals,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
wwoods2 on DSK1DXX6B1PROD with NOTICES_PART 1
Name of Committee: National Advisory
Council on Minority Health and Health
Disparities.
Date: June 8, 2010.
Closed: 8 a.m. to 9 a.m.
Agenda: To review and evaluate grant
applications and/or proposals.
Place: Bethesda Marriott Suites, 6711
Democracy Boulevard, Bethesda, MD 20817.
Open: 9 a.m. to 5 p.m.
Agenda: The agenda will include opening
remarks, administrative matters, Director’s
Report, NIH Health Disparities update, and
other business of the Council.
Place: Bethesda Marriott Suites, 6711
Democracy Boulevard, Bethesda, MD 20817.
Contact Person: Donna Brooks, Asst.
Director for Administration, National Center
on Minority Health and Heath Disparities,
National Institutes of Health, 6707
Democracy Blvd., Suite 800, Bethesda, MD
20892, (301) 435–2135.
Any member of the public interested
in presenting oral comments to the
committee may notify the Contact
Person listed on this notice at least 10
days in advance of the meeting.
Interested individuals and
representatives of organizations may
submit a letter of intent, a brief
description of the organization
represented, and a short description of
the oral presentation. Only one
representative of an organization may be
allowed to present oral comments and if
accepted by the committee,
presentations may be limited to five
minutes. Both printed and electronic
copies are requested for the record. In
addition, any interested person may file
written comments with the committee
by forwarding their statement to the
Contact Person listed on this notice. The
statement should include the name,
address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
Dated: May 14, 2010.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2010–12153 Filed 5–19–10; 8:45 am]
BILLING CODE 4140–01–P
VerDate Mar<15>2010
15:45 May 19, 2010
Jkt 220001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Part C Early Intervention Services
Grant Under the Ryan White HIV/AIDS
Program
AGENCY: Health Resources and Services
Administration (HRSA), HHS .
ACTION: Notice of Non-competitive
Award of Part C Funds for the Rural
Health Group.
SUMMARY: HRSA will be awarding noncompetitively Part C funds to support
comprehensive primary care services for
persons living with HIV/AIDS,
including primary medical care,
laboratory testing, oral health care,
outpatient mental health and substance
abuse treatment, specialty and
subspecialty care, referrals for health
and support services and adherence
monitoring/education services to the
Rural Health Group in order to ensure
continuity of critical HIV medical care
and treatment services, and to avoid a
disruption of HIV clinical care to clients
in Henderson, North Carolina, and the
surrounding counties.
SUPPLEMENTARY INFORMATION:
Grantee of record: Maria Parham
Medical Center, Henderson, North
Carolina.
Intended recipient of the award: Rural
Health Group, Roanoke Rapids, North
Carolina.
Amount of the award: $426,562 to
ensure ongoing clinical services to the
target population.
Authority: Section 2651 of the Public
Health Service Act, 42 U.S.C. 300ff-51.
CFDA Number: 93.918.
Project period: April 1, 2010, to June
30, 2011. The period of support for this
award is from April 1, 2010, to June 30,
2011.
Justification for the Exception to
Competition
Critical funding for HIV medical care
and treatment services to clients in
northern North Carolina will be
continued through a non-competitive
award to the Rural Health Group,
because it has the fiscal and
administrative infrastructure to
administer the Part C Grant. This is a
temporary replacement award, as the
previous grant recipient serving this
population notified HRSA that it could
not continue providing services after
March 31, 2010. HRSA’s HIV/AIDS
Bureau identified the Rural Health
Group as the best qualified entity for
this temporary grant, because it is a
PO 00000
Frm 00034
Fmt 4703
Sfmt 4703
28263
community health center funded by
section 330 of the Public Health Service
Act. As of January 1, 2010, the Maria
Parham Medical Center has contracted
with the Rural Health Group to provide
services temporarily, and the program
staff has been transferred to the Rural
Health Group. The Rural Health Group
can ensure comprehensive services are
provided including primary medical
care including antiretroviral therapies;
prevention education and medication
adherence teaching; referrals for mental
health, substance abuse and dental
services; and on-site medical HIV case
management services. The additional
funding provided would enhance
retaining the targeted population in
care. The Rural Health Group is able to
provide critical services with the least
amount of disruption to the service
population while the service area is recompeted.
This supplement will cover the time
period from April 1, 2010, through June
30, 2011. This service area will be
included in the upcoming competition
for the Part C HIV Early Intervention
Services for project periods starting July,
2011.
FOR FURTHER INFORMATION CONTACT:
Kathleen Treat, by e-mail
ktreat@hrsa.gov, or by phone at 301–
443–7602.
Dated: May 12, 2010.
Mary K. Wakefield,
Administrator.
[FR Doc. 2010–12047 Filed 5–19–10; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2010–N–0085]
Preventive Controls for Fresh Produce;
Request for Comments; Extension of
the Comment Period
AGENCY:
Food and Drug Administration,
HHS.
ACTION: Notice; extension of the
comment period.
SUMMARY: The Food and Drug
Administration (FDA) is extending to
July 23, 2010, the comment period for
a notice that appeared in the Federal
Register of February 23, 2010 (75 FR
8086). In that notice, FDA established a
docket to obtain comments and
information about current practices and
conditions for the production and
packing of fresh produce. The agency is
extending this comment period to give
interested parties additional time to
E:\FR\FM\20MYN1.SGM
20MYN1
]]>Agencies
[Federal Register Volume 75, Number 97 (Thursday, May 20, 2010)]
[Notices]
[Pages 28262-28263]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-12153]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Center on Minority Health and Health Disparities; Notice
of Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of a meeting of the
National Advisory Council on Minority Health and Health Disparities.
The meeting will be open to the public as indicated below, with
attendance limited to space available. Individuals who plan to attend
and need special assistance, such as sign language interpretation or
other reasonable accommodations, should notify the Contact Person
listed below in advance of the meeting.
The meeting will be closed to the public in accordance with the
[[Page 28263]]
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and/or contract proposals
and the discussions could disclose confidential trade secrets or
commercial property such as patentable material, and personal
information concerning individuals associated with the grant
applications and/or contract proposals, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Advisory Council on Minority Health
and Health Disparities.
Date: June 8, 2010.
Closed: 8 a.m. to 9 a.m.
Agenda: To review and evaluate grant applications and/or
proposals.
Place: Bethesda Marriott Suites, 6711 Democracy Boulevard,
Bethesda, MD 20817.
Open: 9 a.m. to 5 p.m.
Agenda: The agenda will include opening remarks, administrative
matters, Director's Report, NIH Health Disparities update, and other
business of the Council.
Place: Bethesda Marriott Suites, 6711 Democracy Boulevard,
Bethesda, MD 20817.
Contact Person: Donna Brooks, Asst. Director for Administration,
National Center on Minority Health and Heath Disparities, National
Institutes of Health, 6707 Democracy Blvd., Suite 800, Bethesda, MD
20892, (301) 435-2135.
Any member of the public interested in presenting oral comments to
the committee may notify the Contact Person listed on this notice at
least 10 days in advance of the meeting. Interested individuals and
representatives of organizations may submit a letter of intent, a brief
description of the organization represented, and a short description of
the oral presentation. Only one representative of an organization may
be allowed to present oral comments and if accepted by the committee,
presentations may be limited to five minutes. Both printed and
electronic copies are requested for the record. In addition, any
interested person may file written comments with the committee by
forwarding their statement to the Contact Person listed on this notice.
The statement should include the name, address, telephone number and
when applicable, the business or professional affiliation of the
interested person.
Dated: May 14, 2010.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2010-12153 Filed 5-19-10; 8:45 am]
BILLING CODE 4140-01-P
